Vedroprevir
Tier C — Watch / tradeVedroprevir
Targets：NS3/NS4A
Indications (approved)：慢性炎症性脱髓鞘性多发性神经病, Chronic hepatitis C, Hepatitis C
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| VEDR-001 | 1499-56-5 | (2S,4R)-methyl 4-hydroxypyrrolidine-2-carboxylate |
| VEDR-002 | 98-58-8 | 4-bromobenzene-1-sulfonyl chloride |
| VEDR-003 | 1001098-63-0 | (2S,4S)-methyl 4-(((4-bromophenyl)sulfonyl)oxy)pyrrolidine-2-carboxylate hydrochloride |
| VEDR-004 | 62965-35-9 | (S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoic acid |
| VEDR-005 | 1098181-40-8 | (2S,4S)-methyl 4-(((4-bromophenyl)sulfonyl)oxy)-1-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)pyrrolidine-2-carboxylate |
| VEDR-006 | 1098181-41-9 | (2S,4S)-4-(((4-bromophenyl)sulfonyl)oxy)-1-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)pyrrolidine-2-carboxylic acid |
| VEDR-007 | 772326-49-5 | (1R,2R)-methyl 1-amino-2-ethylcyclopropanecarboxylate |
| VEDR-008 | 1098198-84-5 | (1R,2R)-methyl 1-((2S,4S)-4-(((4-bromophenyl)sulfonyl)oxy)-1-((S)-2-((tert-butoxycarbonyl)amino)-3,3-dimethylbutanoyl)pyrrolidine-2-carboxamido)-2-ethylcyclopropanecarboxylate |
| VEDR-009 | 1098198-75-4 | (1R,3r,5S)-bicyclo[3.1.0]hexan-3-yl (2,5-dioxopyrrolidin-1-yl) carbonate |
| VEDR-010 | 1098189-07-1 | (1R,2R)-methyl 1-((2S,4S)-1-((S)-2-((((1R,3r,5S)-bicyclo[3.1.0]hexan-3-yloxy)carbonyl)amino)-3,3-dimethylbutanoyl)-4-(((4-bromophenyl)sulfonyl)oxy)pyrrolidine-2-carboxamido)-2-ethylcyclopropanecarboxylate |
| VEDR-011 | 1098189-06-0 | 8-chloro-7-(2,2-dimethoxyethoxy)-2-(2-(isopropylamino)thiazol-4-yl)quinolin-4-ol |
| VEDR-012 | 1098189-09-3 | (1R,2R)-methyl 1-((2S,4R)-1-((S)-2-((((1R,3r,5S)-bicyclo[3.1.0]hexan-3-yloxy)carbonyl)amino)-3,3-dimethylbutanoyl)-4-((8-chloro-7-(2,2-dimethoxyethoxy)-2-(2-(isopropylamino)thiazol-4-yl)quinolin-4-yl)oxy)pyrrolidine-2-carboxamido)-2-ethylcyclopropanecarboxylate |
| VEDR-013 | 1098189-14-0 | (1R,2R)-methyl 1-((2S,4R)-1-((S)-2-((((1R,3r,5S)-bicyclo[3.1.0]hexan-3-yloxy)carbonyl)amino)-3,3-dimethylbutanoyl)-4-((8-chloro-2-(2-(isopropylamino)thiazol-4-yl)-7-(2-morpholinoethoxy)quinolin-4-yl)oxy)pyrrolidine-2-carboxamido)-2-ethylcyclopropanecarboxylate |
| VEDR-014 | 14320-38-8 | cyclopent-3-en-1-ol |
| VEDR-015 | 694-43-9 | (1R,3r,5S)-bicyclo[3.1.0]hexan-3-ol |
| VEDR-016 | 74124-79-1 | bis(2,5-dioxopyrrolidin-1-yl) carbonate |
| VEDR-017 | 923289-36-5 | 1-(2-amino-3-chloro-4-methoxyphenyl)ethanone |
| VEDR-018 | 1098189-00-4 | 1-(2-amino-3-chloro-4-hydroxyphenyl)ethanone |
| VEDR-019 | 7252-83-7Available | 2-bromo-1,1-dimethoxyethane |
| VEDR-020 | 1098189-01-5 | 1-(2-amino-3-chloro-4-(2,2-dimethoxyethoxy)phenyl)ethanone |
| VEDR-021 | 760934-24-5 | 2-(isopropylamino)thiazole-4-carboxylic acid |
| VEDR-022 | 1098189-05-9 | N-(6-acetyl-2-chloro-3-(2,2-dimethoxyethoxy)phenyl)-2-(isopropylamino)thiazole-4-carboxamide |
Frequently asked questions
What are the approved indications of Vedroprevir?
Approved indications include: 慢性炎症性脱髓鞘性多发性神经病, Chronic hepatitis C, Hepatitis C.
When does the Vedroprevir patent expire?
No public expiry year is available for Vedroprevir yet; this page updates once verified.
How many synthesis routes are recorded for Vedroprevir?
1 synthesis routes are recorded; the shortest is 14 steps with / total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Vedroprevir intermediates?
1 intermediate CAS of Vedroprevir are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Vedroprevir intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-02